Home > Healthcare > Medical Devices > Medical Supplies > Intrauterine Devices Market

Intrauterine Devices Market Trends

Report ID: GMI5451
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Intrauterine Devices Market Trends

Recent technological advancements in the design and insertion techniques of intrauterine devices (IUDs) have significantly contributed to the growth of the IUD market. These innovations aim to enhance the safety, effectiveness, and ease of use of IUDs, making them a more attractive option for contraception.

Improvements in IUD design and materials have significantly reduced discomfort and side effects, making IUDs more acceptable to a wider range of women.
Additionally, the development of more advanced insertion kits that are easier to use has improved the safety and efficiency of the insertion process. These kits often include pre-loaded IUDs and ergonomic applicators.
Moreover, the advances in hormone delivery and longer-lasting copper IUDs offer extended protection, providing a more reliable and convenient contraception method.
Furthermore, research and development are ongoing for smart IUDs that can monitor and report data on hormone levels and uterine environment, providing personalized healthcare insights and timely interventions.
These technological advancements and their resulting benefits play a crucial role in driving the growth of the IUD market by making them a more viable and appealing contraceptives for women worldwide.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Intrauterine devices industry size was worth USD 4.3 billion in 2023 and will expand at 10.3% CAGR between 2024 and 2032, owing to the increasing awareness of long-term contraceptive options along with the rising demand for effective, reversible birth control methods.

The hormonal IUD segment registered USD 2.3 billion in 2023, propelled by its high efficacy, long-term protection, and additional health benefits, such as reduced menstrual bleeding and pain.

North America intrauterine devices industry achieved USD 1.5 billion in 2023 due to high awareness of reproductive health and widespread availability of advanced contraceptive options.

Major firms including Bayer AG, Contrel Europe, CooperSurgical Inc., Durbin, EUROGINE, S.L, Gima S.p.A., HLL Lifecare Limited, Meril Life Sciences Pvt. Ltd., Mona Lisa N.V., Mylan N.V. (Viatris), OCON Medical Ltd., Pregna International Ltd., Prosan International BV, and SMB Corporation of India, are operating in the market.